Baillie Gifford - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$13,466
+43.4%
278
+13.0%
0.00%
Q4 2022$9,390
-21.8%
2460.0%0.00%
Q3 2022$12,000
+20.0%
2460.0%0.00%
Q2 2022$10,000
+11.1%
2460.0%0.00%
Q1 2022$9,000
-10.0%
2460.0%0.00%
Q4 2021$10,000
+11.1%
2460.0%0.00%
Q3 2021$9,000
-10.0%
2460.0%0.00%
Q2 2021$10,000
-16.7%
2460.0%0.00%
Q1 2021$12,000
-20.0%
2460.0%0.00%
Q4 2020$15,0002460.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders